Standard

EGFR Suppression Inhibits the Sphere Formation of MCF7 Cells Overexpressing EGFR. / Novak, D D; Troitskaya, O S; Nushtaeva, A A et al.

In: Acta Naturae, Vol. 15, No. 2, 7, 2023, p. 59-69.

Research output: Contribution to journalArticlepeer-review

Harvard

Novak, DD, Troitskaya, OS, Nushtaeva, AA, Zhilnikova, MV, Richter, VA, Meschaninova, MI & Koval, OA 2023, 'EGFR Suppression Inhibits the Sphere Formation of MCF7 Cells Overexpressing EGFR', Acta Naturae, vol. 15, no. 2, 7, pp. 59-69. https://doi.org/10.32607/actanaturae.17857

APA

Novak, D. D., Troitskaya, O. S., Nushtaeva, A. A., Zhilnikova, M. V., Richter, V. A., Meschaninova, M. I., & Koval, O. A. (2023). EGFR Suppression Inhibits the Sphere Formation of MCF7 Cells Overexpressing EGFR. Acta Naturae, 15(2), 59-69. [7]. https://doi.org/10.32607/actanaturae.17857

Vancouver

Novak DD, Troitskaya OS, Nushtaeva AA, Zhilnikova MV, Richter VA, Meschaninova MI et al. EGFR Suppression Inhibits the Sphere Formation of MCF7 Cells Overexpressing EGFR. Acta Naturae. 2023;15(2):59-69. 7. doi: 10.32607/actanaturae.17857

Author

Novak, D D ; Troitskaya, O S ; Nushtaeva, A A et al. / EGFR Suppression Inhibits the Sphere Formation of MCF7 Cells Overexpressing EGFR. In: Acta Naturae. 2023 ; Vol. 15, No. 2. pp. 59-69.

BibTeX

@article{df72fe6e5fd642468f0d1e1c3678861c,
title = "EGFR Suppression Inhibits the Sphere Formation of MCF7 Cells Overexpressing EGFR",
abstract = "The epidermal growth factor receptor (EGFR) is an oncogenic tyrosine kinase that is involved in tumor initiation and progression, making EGFR inhibitors and monoclonal antibodies to this receptor essential for anti-tumor therapy. We have previously shown that EGFR transgene expression in the human breast adenocarcinoma cell line MCF7 (MCF7-EGFR) stimulates the 3D spheroid-like growth. The primary focus of our present work was to investigate whether EGFR inhibition could affect the assembly of spheroids or lead to the destruction of pre-existing spheroids. We compared the effects of anti-EGFR siRNA, the anti-EGFR monoclonal antibody cetuximab, and the tyrosine kinase inhibitor AG1478 on dissociated and spheroid MCF7-EGFR cells. MCF7-EGFR cells were found to have a 2.5-fold higher sensitivity towards the cytotoxic effects of cetuximab and AG1478 compared with the parental MCF7 cell line. The suppression of EGFR mRNA with siRNA was found to reduce the sphere formation, whereas treating the pre-existing spheroids had no such effect. Treatment of dissociated spheroids with cetuximab and AG1478 was also found to inhibit the MCF7-EGFR sphere formation. We suggest that EGFR expression is important, at least, during the spheroid formation stage. The transition of a MCF7wt adherent cell culture to MCF7-EGFR spheroids was accompanied by a considerable increase in N-cadherin adhesion proteins. The level of N-cadherin decreased when MCF7-EGFR cells were treated with siRNA and cetuximab. Thus, we have demonstrated that N-cadherin is involved in the EGFR-dependent formation of MCF7-EGFR spheroids. Accordingly, MCF7-EGFR spheroids can be considered a suitable model for studying aggressive hormone-positive breast tumors.",
keywords = "3D-культура клеток, сфероиды, MCF7, EGFR, siРНК, цетуксимаб, AG1478, 3D cell culture, AG1478, EGFR, MCF7, cetuximab, siRNA, spheroids",
author = "Novak, {D D} and Troitskaya, {O S} and Nushtaeva, {A A} and Zhilnikova, {M V} and Richter, {V A} and Meschaninova, {M I} and Koval, {O A}",
note = "This research was supported by the Russian Science Foundation grant No. 20-74-10039 (cultivation of cancer cells and spheroids), Novosibirsk Government grant No. 7 (Gr-7) (experiments with siRNA,) and the budget funding project No. 121030200173-6 (experiments with cetuximab). Copyright {\textregistered} 2023 National Research University Higher School of Economics.",
year = "2023",
doi = "10.32607/actanaturae.17857",
language = "English",
volume = "15",
pages = "59--69",
journal = "Acta Naturae",
issn = "2075-8251",
publisher = "Park Media Ltd.",
number = "2",

}

RIS

TY - JOUR

T1 - EGFR Suppression Inhibits the Sphere Formation of MCF7 Cells Overexpressing EGFR

AU - Novak, D D

AU - Troitskaya, O S

AU - Nushtaeva, A A

AU - Zhilnikova, M V

AU - Richter, V A

AU - Meschaninova, M I

AU - Koval, O A

N1 - This research was supported by the Russian Science Foundation grant No. 20-74-10039 (cultivation of cancer cells and spheroids), Novosibirsk Government grant No. 7 (Gr-7) (experiments with siRNA,) and the budget funding project No. 121030200173-6 (experiments with cetuximab). Copyright ® 2023 National Research University Higher School of Economics.

PY - 2023

Y1 - 2023

N2 - The epidermal growth factor receptor (EGFR) is an oncogenic tyrosine kinase that is involved in tumor initiation and progression, making EGFR inhibitors and monoclonal antibodies to this receptor essential for anti-tumor therapy. We have previously shown that EGFR transgene expression in the human breast adenocarcinoma cell line MCF7 (MCF7-EGFR) stimulates the 3D spheroid-like growth. The primary focus of our present work was to investigate whether EGFR inhibition could affect the assembly of spheroids or lead to the destruction of pre-existing spheroids. We compared the effects of anti-EGFR siRNA, the anti-EGFR monoclonal antibody cetuximab, and the tyrosine kinase inhibitor AG1478 on dissociated and spheroid MCF7-EGFR cells. MCF7-EGFR cells were found to have a 2.5-fold higher sensitivity towards the cytotoxic effects of cetuximab and AG1478 compared with the parental MCF7 cell line. The suppression of EGFR mRNA with siRNA was found to reduce the sphere formation, whereas treating the pre-existing spheroids had no such effect. Treatment of dissociated spheroids with cetuximab and AG1478 was also found to inhibit the MCF7-EGFR sphere formation. We suggest that EGFR expression is important, at least, during the spheroid formation stage. The transition of a MCF7wt adherent cell culture to MCF7-EGFR spheroids was accompanied by a considerable increase in N-cadherin adhesion proteins. The level of N-cadherin decreased when MCF7-EGFR cells were treated with siRNA and cetuximab. Thus, we have demonstrated that N-cadherin is involved in the EGFR-dependent formation of MCF7-EGFR spheroids. Accordingly, MCF7-EGFR spheroids can be considered a suitable model for studying aggressive hormone-positive breast tumors.

AB - The epidermal growth factor receptor (EGFR) is an oncogenic tyrosine kinase that is involved in tumor initiation and progression, making EGFR inhibitors and monoclonal antibodies to this receptor essential for anti-tumor therapy. We have previously shown that EGFR transgene expression in the human breast adenocarcinoma cell line MCF7 (MCF7-EGFR) stimulates the 3D spheroid-like growth. The primary focus of our present work was to investigate whether EGFR inhibition could affect the assembly of spheroids or lead to the destruction of pre-existing spheroids. We compared the effects of anti-EGFR siRNA, the anti-EGFR monoclonal antibody cetuximab, and the tyrosine kinase inhibitor AG1478 on dissociated and spheroid MCF7-EGFR cells. MCF7-EGFR cells were found to have a 2.5-fold higher sensitivity towards the cytotoxic effects of cetuximab and AG1478 compared with the parental MCF7 cell line. The suppression of EGFR mRNA with siRNA was found to reduce the sphere formation, whereas treating the pre-existing spheroids had no such effect. Treatment of dissociated spheroids with cetuximab and AG1478 was also found to inhibit the MCF7-EGFR sphere formation. We suggest that EGFR expression is important, at least, during the spheroid formation stage. The transition of a MCF7wt adherent cell culture to MCF7-EGFR spheroids was accompanied by a considerable increase in N-cadherin adhesion proteins. The level of N-cadherin decreased when MCF7-EGFR cells were treated with siRNA and cetuximab. Thus, we have demonstrated that N-cadherin is involved in the EGFR-dependent formation of MCF7-EGFR spheroids. Accordingly, MCF7-EGFR spheroids can be considered a suitable model for studying aggressive hormone-positive breast tumors.

KW - 3D-культура клеток

KW - сфероиды

KW - MCF7

KW - EGFR

KW - siРНК

KW - цетуксимаб

KW - AG1478

KW - 3D cell culture

KW - AG1478

KW - EGFR

KW - MCF7

KW - cetuximab

KW - siRNA

KW - spheroids

UR - https://www.scopus.com/record/display.uri?eid=2-s2.0-85169060564&origin=inward&txGid=1120c24a75bfa261be8e2d596b9873f2

UR - https://www.mendeley.com/catalogue/21ce1ce3-b03b-39e9-bca0-b23510c6d4cf/

U2 - 10.32607/actanaturae.17857

DO - 10.32607/actanaturae.17857

M3 - Article

C2 - 37538799

VL - 15

SP - 59

EP - 69

JO - Acta Naturae

JF - Acta Naturae

SN - 2075-8251

IS - 2

M1 - 7

ER -

ID: 53584387